United States - English - NLM (National Library of Medicine)

apotex corp. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ]. for the management of the signs and symptoms of ra [see clinical studies (14.2) ]. for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ]. for the management of the signs and symptoms of as [see clinical studies (14.4) ]. for the management of acute pain in adults [see clinical studies (14.5) ]. for the management of primary dysmenorrhea [see clinical studies (14.5) ]. celecoxib capsules are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids, have been reported in such patients [see warnings and precautions (

United States - English - NLM (National Library of Medicine)

greenstone llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - celecoxib is indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ]. for the management of the signs and symptoms of ra [see clinical studies (14.2) ]. for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ]. for the management of the signs and symptoms of as [see clinical studies (14.4) ]. for the management of acute pain in adults [see clinical studies (14.5) ]. for the management of primary dysmenorrhea [see clinical studies (14.5) ]. celecoxib is contraindicated in the following patients: risk summary use of nsaids, including celecoxib, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. because of these risks, limit dose and duration of celecoxib use between about 20 and 30 weeks of gestation and avoid celecoxib use at about 30 weeks of gestation and later in pregnancy (see clinical considerations, data )

United States - English - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [ see clinical studies (14.1) ]. for the management of the signs and symptoms of ra [ see clinical studies (14.2) ]. for the management of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ]. for the management of the signs and symptoms of as [ see clinical studies (14.4) ]. for the management of acute pain in adults [ see clinical studies (14.5) ]. for the management of primary dysmenorrhea [ see clinical studies (14.5) ]. celecoxib capsules are contraindicated in the following patients : - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. -

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [ see clinical studies (14.1) ]. for the management of the signs and symptoms of ra [ see clinical studies (14.2) ]. for the management of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ]. for the management of the signs and symptoms of as [ see clinical studies (14.4) ]. for the management of acute pain in adults [ see clinical studies (14.5) ]. for the management of primary dysmenorrhea [ see clinical studies (14.5) ]. celecoxib capsules are contraindicated in the following patients : - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaid

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - celecoxib -

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals limited - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4) ]  celecoxib is indicated for the management of ap in adults [see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [see clinical studies (14.5) ] celecoxib is contraindicated: - in patients with known hypersensitivity to celecoxib, aspirin, or other nsaids. - in patients who have demonstrated allergic-type rea

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated 1.1 osteoarthritis for the management of the signs and symptoms of oa [see clinical studies (14.1)] 1.2 rheumatoid arthritis for the management of the signs and symptoms of ra [see clinical studies (14.2)] 1.3 juvenile rheumatoid arthritis for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] 1.4 ankylosing spondylitis for the management of the signs and symptoms of as [see clinical studies (14.4)] 1.5 acute pain for the management of acute pain in adults [see clinical studies (14.5)] 1.6 primary dysmenorrhea for the management of primary dysmenorrhea [see clinical studies (14.5)] • celecoxib capsules are contraindicated in the following patients: known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)]. • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsai

United States - English - NLM (National Library of Medicine)

direct_rx - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated 1.1 osteoarthritis (oa) for the management of the signs and symptoms of oa [see clinical studies (14.1)] 1.2 rheumatoid arthritis (ra) for the management of the signs and symptoms of ra [see clinical studies (14.2)] 1.3 juvenile rheumatoid arthritis(jra) for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] 1.4 ankylosing spondylitis (as) for the management of the signs and symptoms of as [see clinical studies (14.4)] 1.5 acute pain for the management of acute pain in adults [see clinical studies (14.5)] 1.6 primary dysmenorrhea for the management of primary dysmenorrhea [see clinical studies (14.5)] celecoxib capsules are contraindicated in the following patients: known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)]. history of asthma, urticaria, or other allergic-type reactions after taking aspir

United States - English - NLM (National Library of Medicine)

direct_rx - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated 1.1 osteoarthritis (oa) for the management of the signs and symptoms of oa [see clinical studies (14.1)] 1.2 rheumatoid arthritis (ra) for the management of the signs and symptoms of ra [see clinical studies (14.2)] 1.3 juvenile rheumatoid arthritis(jra) for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] 1.4 ankylosing spondylitis (as) for the management of the signs and symptoms of as [see clinical studies (14.4)] 1.5 acute pain for the management of acute pain in adults [see clinical studies (14.5)] 1.6 primary dysmenorrhea for the management of primary dysmenorrhea [see clinical studies (14.5)] celecoxib capsules are contraindicated in the following patients: known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)]. history of asthma, urticaria, or other allergic-type reactions after taking aspir

United States - English - NLM (National Library of Medicine)

direct_rx - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated 1.1 osteoarthritis for the management of the signs and symptoms of oa [see clinical studies (14.1)] 1.2 rheumatoid arthritis for the management of the signs and symptoms of ra [see clinical studies (14.2)] 1.3 juvenile rheumatoid arthritis for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] 1.4 ankylosing spondylitis for the management of the signs and symptoms of as [see clinical studies (14.4)] 1.5 acute pain for the management of acute pain in adults [see clinical studies (14.5)] 1.6 primary dysmenorrhea for the management of primary dysmenorrhea [see clinical studies (14.5)] • celecoxib capsules are contraindicated in the following patients: known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)]. • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsai